Neuroprotective effects of erythropoietin on neurodegenerative and ischemic brain diseases: the role of erythropoietin receptor1381-1389
Post electrical or lightning injury syndrome: a proposal for an American Psychiatric Association's Diagnostic and Statistical Manual formulation with implications for treatment1405-1412
Tp53 gene mediates distinct dopaminergic neuronal damage in different dopaminergic neurotoxicant models1413-1417
Therapeutic potential of α7 nicotinic receptor agonists to regulate neuroinflammation in neurodegenerative diseases1418-1421
Relevance and therapeutic potential of CypA targeting to block apoptosis inducing factor-mediated neuronal cell death1428-1429
Extracellular matrix based biomaterials for central nervous system tissue repair: the benefits and drawbacks1430-1432
